MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA)
$3.87
N/A ( 0% ) 45.0K
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Market Data
Open
$3.87
Previous close
$3.87
Volume
45.0K
Market cap
$80.80M
Day range
$3.69 - $3.90
52 week range
$0.82 - $5.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 15, 2024 |
10-q | Quarterly Reports | 54 | May 14, 2024 |
8-k | 8K-related | 47 | May 07, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |
4 | Insider transactions | 1 | Apr 30, 2024 |
4 | Insider transactions | 1 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 26, 2024 |
8-k | 8K-related | 17 | Apr 23, 2024 |
def | Proxies and info statements | 3 | Apr 16, 2024 |